World Health Organization Classification of Tumours

By Cdm Fletcher, E. W. D. Berg, Ineke Molenaar. 2002

7,210 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/c513db85a9bdfa756057dcec4f45cdee900441f0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Rajkumar
2. Humayun Irshad
3. Michael Weller
4. C. Hartmann
5. B. Hentschel
6. Shaji K. Kumar
7. Guido Reifenberger
8. Wolfgang Wick

Citations in the corpus

• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022, background): “The World Health Organization (WHO) classification of lymphoid tumours has provided a global reference for the diagnosis of lymphoid neoplasms since its 3 edition in 2001 [1] which was based on the R.”
• Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas (2010, methodology): “) at the German Brain Tumor Reference Center of the German Society for Neuropathology and Neuroanatomy (DGNN) according to the revised WHO 2000 and 2007 classifications [11], assuring identical histological classification and grading.”